Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
FinWise Bancorp
FINW
$191M
| $263K | ﹤0.01% |
14,634
+1,786
| +14% | +$32.6K |
|
4127
Legacy Housing
LEGH
$683M
| $261K | ﹤0.01% |
13,394
+1,081
| +9% | +$23.2K |
|
|
GME.WS
4128
GameStop Corp Warrants
GME.WS
| $261K | ﹤0.01% |
+86,707
| New | +$269K |
|
|
MDV
4129
Modiv Industrial
MDV
$186M
| $260K | ﹤0.01% |
18,088
+4,863
| +37% | +$70.8K |
|
4130
RCM Technologies
RCMT
$202M
| $260K | ﹤0.01% |
12,717
+2,216
| +21% | +$47.6K |
|
4131
SoundThinking
SSTI
$106M
| $260K | ﹤0.01% |
32,365
+1,347
| +4% | +$11.7K |
|
4132
PUT
Academy Sports + Outdoors
ASO
$3.05B
| $260K | ﹤0.01% |
5,200
-762,000
| -99% | -$37.8M |
|
4133
OP Bancorp
OPBK
$235M
| $259K | ﹤0.01% |
18,376
+1,754
| +11% | +$24K |
|
4134
Tucows
TCX
$140M
| $259K | ﹤0.01% |
11,571
+2,059
| +22% | +$41.8K |
|
4135
Perrigo
PRGO
$1.76B
| $259K | ﹤0.01% |
18,618
-122,780
| -87% | -$2.05M |
|
4136
CALL
Phillips 66
PSX
$90B
| $258K | ﹤0.01% |
2,000
-19,300
| -91% | -$2.6M |
|
|
JMIA
4137
Jumia Technologies
JMIA
$793M
| $256K | ﹤0.01% |
20,500
+1,500
| +8% | +$17.3K |
|
|
XMAY
4138
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - May
XMAY
$19.3M
| $256K | ﹤0.01% |
7,333
-624
| -8% | -$21.5K |
|
4139
Motorcar Parts of America
MPAA
$230M
| $256K | ﹤0.01% |
20,720
+1,196
| +6% | +$17.2K |
|
|
BFIN
4140
DELISTED
BankFinancial
BFIN
| $256K | ﹤0.01% |
21,302
+5,448
| +34% | +$64.4K |
|
4141
Perspective Therapeutics
CATX
$372M
| $255K | ﹤0.01% |
92,791
+8,936
| +11% | +$25.5K |
|
4142
Zura Bio
ZURA
$552M
| $255K | ﹤0.01% |
48,661
+48,659
| +2,432,950% | +$192K |
|
4143
Westrock Coffee
WEST
$807M
| $255K | ﹤0.01% |
62,538
+10,039
| +19% | +$43.9K |
|
4144
iShares Short Maturity Bond ETF
NEAR
$4.88B
| $254K | ﹤0.01% |
4,970
| – | – |
|
4145
LiveWire
LVWR
$229M
| $253K | ﹤0.01% |
57,312
+4,750
| +9% | +$22.8K |
|
|
STRS
4146
DELISTED
STRATUS PPTYS INC
STRS
| $252K | ﹤0.01% |
10,428
+1,001
| +11% | +$21K |
|
4147
W&T Offshore
WTI
$555M
| $252K | ﹤0.01% |
154,556
+14,886
| +11% | +$28.6K |
|
|
GME.WS
4148
CALL
GameStop Corp Warrants
GME.WS
| $251K | ﹤0.01% |
+83,550
| New | +$259K |
|
4149
Bally's
BALY
$671M
| $249K | ﹤0.01% |
15,077
+4,540
| +43% | +$74.2K |
|
4150
Scully Royalty
SRL
$90.9M
| $249K | ﹤0.01% |
+29,100
| New | +$178K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.